<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Determination That FORADIL (Formoterol Fumarate) Inhalation Powder, 0.012 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <style>
        body { font-family: Arial, sans-serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { color: #333; }
        .metadata { color: #666; font-size: 0.9em; }
        .summary { margin-top: 20px; line-height: 1.5; }
        .source { margin-top: 20px; }
    </style>
</head>
<body>
    <h1>Determination That FORADIL (Formoterol Fumarate) Inhalation Powder, 0.012 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness</h1>
    <div class="metadata">Published: 2026-02-05 13:28:21</div>
    <div class="summary">The Food and Drug Administration (FDA, the Agency, or we) has determined that FORADIL (formoterol fumarate) inhalation powder, 0.012 milligrams (mg)/inhalation (inh), was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for formoterol fumarate inhalation powder, 0.012 mg/inh, if all other legal and regulatory requirements are met.</div>
    <div class="source">Source: <a href="https://www.federalregister.gov/documents/2023/11/06/2023-24506/determination-that-foradil-formoterol-fumarate-inhalation-powder-0012-milligrams-was-not-withdrawn" target="_blank" rel="noopener noreferrer">https://www.federalregister.gov/documents/2023/11/06/2023-24506/determination-that-foradil-formoterol-fumarate-inhalation-powder-0012-milligrams-was-not-withdrawn</a></div>
</body>
</html>
